24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Polypid
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:50
Upwind: “By thinking like an adversary the research team stays ahead of the curve”
20:44
Anthropic’s $7 billion Decart deal puts a spotlight on its little-known 23-year-old co-founder and chief scientist
17:34
You thought you were talking to AI. Police may see a digital diary
16:45
The nuclear answer to AI's energy problem is running into the climate crisis
More stories
Buzz
Most popular
Daily
Weekly
1
Anthropic closes in on $7 billion Decart deal after beating Nvidia to the table
2
Palo Alto’s CEO bought the dip. Five months later, his $10 million bet is worth $26 million
3
Why Anthropic is willing to pay $6 billion for Decart
4
The 50 most promising Israeli startups - 2026
5
While the world builds more memory chips, Israel could reinvent them
More news
Polypid
6 stories about Polypid
Biotech Company Polypid Raises $15 Million
07.11.18
|
Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
CTech’s Sunday Roundup of Israeli Tech News
25.03.18
|
CTech
U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO
Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO
25.03.18
|
Dror Reich
The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week
CTech’s Thursday Israeli Tech News Roundup
15.03.18
|
CTech
Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees
Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO
15.03.18
|
Dror Reich
The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery
Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO
11.02.18
|
Dror Reich
The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities